Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BIOMED CONSULTING AS
AS
Active
Org 979918569
Nedre Vei 7D, 3183 Horten
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 1998
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 955K
-20% vs 2023
EBITDA margin
77.6%
-30% vs 2023
Equity ratio
96.3%
Financial strength
Net profit 2024
NOK 1,4M
+102% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2020
1M
0%
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 955K
-20%
EBITDA
NOK 741K
-30%
Net profit
NOK 1,4M
+102%
Total assets
NOK 5,7M
+30%
Equity
NOK 5,5M
+33%
Employees
1
—
Company information
Legal name
BIOMED CONSULTING AS
Org number
979918569
Legal form
Aksjeselskap
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
1. juni 1998
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Contact
Address
Nedre Vei 7D, 3183 Horten
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Horten
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
1M
2023
1M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
1M
2023
1M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
925
1 129
1 348
1 189
955
Staff expenses
−1
−1
−4
−4
−4
EBITDA
755
1 049
1 188
1 065
741
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
755
1 049
1 188
1 065
741
Net financials
1
−195
−29
−144
805
Profit before tax
756
853
1 158
921
1 546
Tax
166
231
261
234
162
Net profit
590
622
897
686
1 384
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 396
2 815
3 780
4 416
5 734
Equity
2 180
2 553
3 450
4 136
5 519
Long-term debt
0
0
0
0
0
Short-term debt
216
262
331
280
215
Total debt
216
262
331
280
215
Financial ratios
5-year trend
EBITDA margin
77.6%
This company
15.8%
Market median
+391% vs market
2020
2024
Equity ratio
96.3%
This company
38.2%
Market median
+152% vs market
2020
2024
Return on equity
25.1%
This company
18.4%
Market median
+36% vs market
2020
2024
Net profit margin
144.9%
This company
8.1%
Market median
+1689% vs market
2020
2024
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
2020
2024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
BS
Bjørg Synnøve Rollsten Ege
Deputy Member
Deputy Member
1998
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
TS
Torfinn Steinar Ege
Chairman
1998
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Therese Ege Hære
Individual
12%
12%
2022
Cathrine Ege-Stokmo
Individual
12%
12%
2022
Andreas Rollsten Ege
Individual
12%
12%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BIOMED CONSULTING AS also hold positions in
0
other companies.
Person
Role here
Other companies
Bjørg Synnøve Rollsten Ege
Deputy Member
0 companies
Torfinn Steinar Ege
Chairman
0 companies